These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 20688246)

  • 1. Diagnostic approach to ANCA-associated vasculitides.
    Gaffo AL
    Rheum Dis Clin North Am; 2010 Aug; 36(3):491-506. PubMed ID: 20688246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
    Lally L; Spiera R
    Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
    Csernok E; Lamprecht P; Gross WL
    Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L43. Seropositive and negative ANCA-associated vasculitis, anti-MPO and PR3-vasculitis: different outcomes?
    Holle JU
    Presse Med; 2013 Apr; 42(4 Pt 2):616-9. PubMed ID: 23481358
    [No Abstract]   [Full Text] [Related]  

  • 5. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
    Ozaki S
    Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
    Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL
    J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Review article: Antineutrophil cytoplasmic antibody in small vessel vasculitis].
    Nakano H; Ozaki S
    Rinsho Byori; 2010 May; 58(5):480-9. PubMed ID: 20560457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do ANCA-associated vasculitides and IgG4-related disease really overlap or not?
    Erden A; Bolek EC; Yardimci KG; Kilic L; Bilgen SA; Karadag O
    Int J Rheum Dis; 2019 Oct; 22(10):1926-1932. PubMed ID: 31571413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Involvement in Antineutrophil Cytoplasmic Antibodies (ANCA)-associated Vasculitis: The Influence of ANCA Subtype.
    Mohammad AJ; Mortensen KH; Babar J; Smith R; Jones RB; Nakagomi D; Sivasothy P; Jayne DRW
    J Rheumatol; 2017 Oct; 44(10):1458-1467. PubMed ID: 28765242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicentre study to improve clinical interpretation of proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibodies.
    Bossuyt X; Rasmussen N; van Paassen P; Hellmich B; Baslund B; Vermeersch P; Blockmans D; Cohen Tervaert JW; Csernok E; Damoiseaux J
    Rheumatology (Oxford); 2017 Sep; 56(9):1533-1541. PubMed ID: 28541581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-neutrophil cytoplasmic antibody(ANCA), MPO-ANCA, PR3-ANCA].
    Takizawa H
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():694-6. PubMed ID: 20942166
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinicoepidemiological manifestations of RPGN and ANCA-associated vasculitides: an 11-year retrospective hospital-based study in Japan.
    Suzuki Y; Takeda Y; Sato D; Kanaguchi Y; Tanaka Y; Kobayashi S; Suzuki K; Hashimoto H; Ozaki S; Horikoshi S; Tomino Y
    Mod Rheumatol; 2010 Feb; 20(1):54-62. PubMed ID: 19821007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular manifestations of ANCA-associated vasculitis.
    Kubal AA; Perez VL
    Rheum Dis Clin North Am; 2010 Aug; 36(3):573-86. PubMed ID: 20688251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
    Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.
    Kallenberg CG; Heeringa P; Stegeman CA
    Nat Clin Pract Rheumatol; 2006 Dec; 2(12):661-70. PubMed ID: 17133251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to improve the histopathological diagnosis of systemic vasculitides in daily practice?
    Honsová E
    Cesk Patol; 2020; 56(2):68-73. PubMed ID: 32493022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L34. Neutrophils in ANCA-associated vasculitis: still under investigation.
    Witko-Sarsat V
    Presse Med; 2013 Apr; 42(4 Pt 2):595-7. PubMed ID: 23481359
    [No Abstract]   [Full Text] [Related]  

  • 19. Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Postgrad Med J; 2014 May; 90(1063):290-6. PubMed ID: 24737903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups.
    Hauer HA; Bajema IM; van Houwelingen HC; Ferrario F; Noël LH; Waldherr R; Jayne DR; Rasmussen N; Bruijn JA; Hagen EC;
    Kidney Int; 2002 Jan; 61(1):80-9. PubMed ID: 11786087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.